Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mutant p53 expression in prostate carcinoma

P J Van Veldhuizen1, R Sadasivan, F Garcia

  • 1Division of Oncology, University of Kansas Medical Center, Kansas City 66160-7353.

The Prostate
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Actual incidence of prostate cancer in healthcare areas of the autonomous community of Castilla-Leon during 2014. CAPCYL registry data.

Actas urologicas espanolas·2018
Same author

Maternal nutritional restriction during late gestation impairs development of the reproductive organs in both male and female lambs.

Theriogenology·2017
Same author

Tenofovir disoproxil fumarate/emtricitabine plus ritonavir-boosted lopinavir or cobicistat-boosted elvitegravir as a single-tablet regimen for HIV post-exposure prophylaxis.

The Journal of antimicrobial chemotherapy·2017
Same author

Relationship Between Sarcopenia and Frailty in the Toledo Study of Healthy Aging: A Population Based Cross-Sectional Study.

Journal of the American Medical Directors Association·2017
Same author

Early detection of HIV infection and of asymptomatic sexually transmitted infections among men who have sex with men.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2017
Same author

Embryonic and post-embryonic development inside wolf spiders' egg sac with special emphasis on the vitellus.

Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology·2017
Same journal

Salvage Androgen Deprivation Therapy Use After Definitive Radiotherapy With vs Without Androgen Deprivation Therapy in Prostate Cancer.

The Prostate·2026
Same journal

A Simple Cell Culture Assay for Human Prostatic Branching Morphogenesis Spotlights Bone Morphogenetic Protein Signaling as a Therapeutic Target in Benign Prostatic Hyperplasia.

The Prostate·2026
Same journal

Temporal Trends of Metastatic Prostate Cancer in the Prostate-Specific Membrane Antigen Positron Emission Tomography Era in the United States.

The Prostate·2026
Same journal

Holmium Laser Enucleation of the Prostate (HoLEP) With Proactive Preservation of One Lateral Lobe: A Technique for Benign Prostatic Hyperplasia to Preserve Sexual Function.

The Prostate·2026
Same journal

Clinical Variable-Based Machine Learning for Predicting Early mCRPC Using Exclusively Clinical Variables: Development and Multicenter External Validation.

The Prostate·2026
Same journal

Association Between Intraoperative Prostate Bed Blood Flow and Postoperative Lower Urinary Tract Symptoms After Robot-Assisted Radical Prostatectomy.

The Prostate·2026
See all related articles

Mutant p53 gene expression is common in prostate cancer. Most tumors showed abnormal p53, often in the cytoplasm, suggesting a role in cancer development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • The p53 tumor suppressor gene plays a critical role in maintaining genomic stability.
  • Mutations in the p53 gene are frequently observed in various human cancers, leading to loss of its tumor-suppressive functions.
  • Understanding p53 expression patterns in prostate cancer is crucial for identifying potential therapeutic targets.

Purpose of the Study:

  • To investigate the expression levels of mutant p53 in human prostate carcinomas.
  • To determine the prevalence and localization of mutant p53 protein within prostate tumor tissues.

Main Methods:

  • Immunohistochemical analysis was performed on 33 human prostate carcinoma samples.
  • Monoclonal antibodies (PAb 1801 and PAb 240) were used to detect mutant p53 expression.

Related Experiment Videos

  • Antibodies against heat shock proteins (HSP 72/73) were employed to investigate potential binding interactions.

    • Main Results:

    • Mutant p53 expression was detected in 79% (26 out of 33) of the prostate tumors analyzed.
    • Positive immunostaining for mutant p53 was predominantly observed in the cytoplasm of glandular tumor cells.
    • Adjacent stromal elements and areas of glandular hyperplasia showed negative staining for mutant p53.
    • The cytoplasmic localization of mutant p53 may be associated with binding to heat shock proteins (HSP 72/73).

    Conclusions:

    • Abnormal p53 expression is a frequent event in prostate cancer.
    • The observed cytoplasmic localization suggests a potential role for p53-HSP interactions in prostate tumorigenesis.
    • These findings highlight the significance of mutant p53 as a potential biomarker or therapeutic target in prostate cancer.